Page last updated: 2024-08-05 11:55:30

monomethoxyflavanone

Any methoxyflavanone that is flavanone substituted by a methoxy group.

ChEBI ID: 38738

Members (9)

MemberDefinitionRole
hesperetinA trihydroxyflavanone having the three hydroxy gropus located at the 3'-, 5- and 7-positions and an additional methoxy substituent at the 4'-position.hesperetin
hesperidinA disaccharide derivative that consists of hesperetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.hesperidin
homoeriodictyolA trihydroxyflavanone that consists of 3'-methoxyflavanone in which the three hydroxy substituents are located at positions 4', 5, and 7.homoeriodictyol
isosakuranetinA dihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5 and 7 and a methoxy group at position 4' (the 2S stereoisomer).4'-methoxy-5,7-dihydroxyflavanone
kurarinolA trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 7, 2' and 4' , a methoxy group at position 5 and a (2S)-5-hydroxy-5-methyl-2-(prop-1-en-2-yl)hexyl group at position 8 respectively.kurarinol
leachianone aA trihydroxyflavanone that is (2S)-flavanone substituted by a lavandulyl group at position 8, hydroxy groups at positions 5, 7 and 4' and a methoxy group at position 2'. Isolated from the roots of Sophora flavescens and Sophora leachiana, it exhibits antineoplastic and antimalarial activity.leachianone A
matteucinolA dihydroxyflavanone that is (2S)-flavanone with hydroxy groups at positions 5 and 7, methyl groups at positions 6 and 8 and a methoxy group at position 4'.matteucinol
pinostrobinA monohydroxyflavanone that is (2S)-flavanone substituted by a hydroxy group at position 5 and a methoxy group at position 7 respectively.pinostrobin
sakuranetinA flavonoid phytoalexin that is (S)-naringenin in which the hydroxy group at position 7 is replaced by a methoxy group.sakuranetin

Research

Studies (2,018)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990133 (6.59)18.7374
1990's107 (5.30)18.2507
2000's345 (17.10)29.6817
2010's926 (45.89)24.3611
2020's507 (25.12)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials138 (5.21%)5.53%
Reviews118 (4.46%)6.00%
Case Studies7 (0.26%)4.05%
Observational7 (0.26%)0.25%
Other2,377 (89.80%)84.16%